相关实验视频

Updated: May 7, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

最近的抗逆转录病毒疗法启动与艾滋病毒相关的加密球菌脑膜炎的死亡风险增加有关:对非洲临床试验数据的分析

Melanie Moyo^1,2, David S Lawrence^3,4, James Jafali¹

¹Malawi-Liverpool-Wellcome Programme, Blantyre, Malawi.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

|July 3, 2025

概括

最近开始抗逆转录病毒疗法 (ART) 的患者中,加密球菌脑膜炎的死亡率更高. 在诊断后不久中断ART可能会改善这些人体免疫缺陷病毒患者的生存率.

科学领域:

传染性疾病传染性疾病
免疫学免疫学免疫学
公共卫生公共卫生

背景情况:

加密球菌脑膜炎是人类免疫缺陷病毒 (HIV) 感染个体的一个重大问题.
超过一半的艾滋病毒相关的加密球菌脑膜炎患者已经接受抗逆转录病毒疗法 (ART).
在最近开始ART (≤14天) 和加密球菌脑膜炎的患者中,对ART的最佳管理尚不清楚.

研究的目的:

调查最近在加密球菌脑膜炎患者中启动ART相关的死亡风险.
确定ART中断对在开始ART后不久被诊断患有密码球菌脑膜炎的患者的结果的影响.

主要方法:

来自Ambisome治疗诱导优化 (AMBITION) 试验的数据分析.
在ART开始后14天内被诊断患有密码球菌脑膜炎的患者的死亡风险的检查.
结合分析与非洲菌性脑膜炎治疗抗真菌组合试验,以评估基于ART状态的基线特征.

主要成果:

在被诊断患有密码球菌脑膜炎的14天内开始治疗ART的患者有20.8%的2周死亡风险.
在长时间接受ART治疗的患者 (>2周至6个月) 中,死亡风险较低.
对于接受ART ≤14天的人来说,与继续ART相比,停止ART将2周死亡率从35%降低到14%.

结论:

最近的ART启动与加密球菌脑膜炎的死亡率增加有关.
最近开始治疗的加密球菌脑膜炎患者中断ART可能会改善结果.
需要进一步的研究来完善这种脆弱人群的ART管理策略.

关键词:

艾滋病艾滋病艾滋病是什么?艾滋病病毒艾滋病病毒艾滋病病毒抗逆转录病毒药物治疗这是一种加密球菌脑膜炎.这种疾病叫做cryptococcosis.

更多相关视频

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.